全文获取类型
收费全文 | 882篇 |
免费 | 44篇 |
国内免费 | 12篇 |
专业分类
耳鼻咽喉 | 5篇 |
儿科学 | 28篇 |
妇产科学 | 33篇 |
基础医学 | 70篇 |
口腔科学 | 30篇 |
临床医学 | 129篇 |
内科学 | 194篇 |
皮肤病学 | 12篇 |
神经病学 | 60篇 |
特种医学 | 101篇 |
外科学 | 128篇 |
综合类 | 21篇 |
预防医学 | 76篇 |
眼科学 | 2篇 |
药学 | 25篇 |
中国医学 | 2篇 |
肿瘤学 | 22篇 |
出版年
2023年 | 6篇 |
2022年 | 12篇 |
2021年 | 14篇 |
2020年 | 10篇 |
2019年 | 12篇 |
2018年 | 21篇 |
2017年 | 13篇 |
2016年 | 15篇 |
2015年 | 12篇 |
2014年 | 18篇 |
2013年 | 29篇 |
2012年 | 26篇 |
2011年 | 31篇 |
2010年 | 31篇 |
2009年 | 34篇 |
2008年 | 34篇 |
2007年 | 47篇 |
2006年 | 26篇 |
2005年 | 20篇 |
2004年 | 14篇 |
2003年 | 24篇 |
2002年 | 24篇 |
2001年 | 9篇 |
2000年 | 15篇 |
1999年 | 15篇 |
1998年 | 31篇 |
1997年 | 37篇 |
1996年 | 35篇 |
1995年 | 30篇 |
1994年 | 19篇 |
1993年 | 22篇 |
1992年 | 11篇 |
1991年 | 6篇 |
1990年 | 23篇 |
1989年 | 17篇 |
1988年 | 25篇 |
1987年 | 24篇 |
1986年 | 16篇 |
1984年 | 6篇 |
1982年 | 7篇 |
1981年 | 6篇 |
1979年 | 8篇 |
1977年 | 13篇 |
1975年 | 6篇 |
1973年 | 5篇 |
1971年 | 9篇 |
1968年 | 5篇 |
1967年 | 6篇 |
1965年 | 5篇 |
1936年 | 5篇 |
排序方式: 共有938条查询结果,搜索用时 15 毫秒
1.
2.
3.
4.
5.
Chronic myeloproliferative disorders: prognostic importance of new working classification 总被引:1,自引:1,他引:0 下载免费PDF全文
Variants of chronic myeloproliferative disorders (CMPD) were compared according to their clinical features and classified by bone marrow biopsy appearances. Subsequently, this classification was further evaluated using survival data and histological variables from iliac crest biopsy specimens of an additional 1391 patients, making a total of 2241 patients available for analysis of outcome. The patients were grouped again into three main classes: "typical"; "variant"; and "transformed". "Typical" comprised the "classic" groups. "Variant" included the less uniform myeloproliferative syndromes, distinguished also by more variable clinical features, a different prognosis, and a greater tendency to fibrotic and blastic transformation. "Transformed" defined the end stages of both "typical" and "variant" types. Ten subgroups were distinguished by different histology and prognosis. Particular prognostic importance was assigned to atypia and immaturity of haemopoiesis, predominance of individual haemopoietic cell line, number and anomalies of megakaryocytes and progressive fibrosis. It is suggested that the proposed subclassification would be helpful for studies of epidemiology and therapeutic trials by allowing more homogeneous groups to be recognised. 相似文献
6.
Studies of proteins that inhibit tissue factor activity have generally been conducted using either an extracted tissue homogenate ("thromboplastin") or tissue factor protein reconstituted into phospholipid vesicles rather than with tissue factor expressed in cell membranes (its physiological environment). In the present study, a human fibroblast cell strain was used to evaluate the effects of lipoprotein associated coagulation inhibitor (LACI), placental anticoagulant protein (PAP), and apolipoprotein A-II (apo A-II) on human tissue factor in cell membranes. LACI was tested from 7.8 to 500 pmol/L on fibroblasts cultured at cell densities ranging from 3,500 to 9,925 cells/well, and caused a progressive inhibition of tissue factor activity. PAP was tested from 3.9 nmol/L to 1 mumol/L at cell densities ranging from 4,500 to 15,400 cells/well and caused up to 83% inhibition of tissue factor activity. Inhibition by these proteins appeared to be influenced by cell density as well as whether the cells were intact or disrupted. Apo A-II, up to 1 mumol/L, did not inhibit the tissue factor activity of intact or disrupted fibroblasts at any cell density examined even though it did inhibit the activity of tissue factor in phospholipid vesicles. Of these inhibitors of tissue factor-dependent activation of factor X, LACI was the most effective in suppressing the generation of factor Xa activity. The effects obtained with apo A-II are clearly dependent on the nature of the tissue factor preparation with which it is tested. The disparity between the inhibitory effect of apo A-II on the activity of tissue factor reconstituted into lipid vesicles and the absence of effect on the activity of tissue factor remaining in cell membranes serves to reemphasize the necessity of reexamining results obtained with model systems using as nearly physiological reagents as possible. 相似文献
7.
Ole Rintek Madsen Ulrik Birk Lauridsen Andreas Hartkopp Ole Helmer Sørensen 《European journal of applied physiology》1997,75(3):239-245
Dual energy x-ray absorptiometry (DEXA) offers the possibility of assessing regional soft tissue composition, i.e. lean mass (LM) and fat mass : LM may be considered a measure of muscle mass. We examined age-related differences in LM, percentage fat (%fat) and muscle strength in 100 healthy non-athletic women aged 18–87 years. Relationships between muscle strength and leg LM in 20 elite female weight lifters and in 18 inactive women with previous hip fractures were also studied. The LM and %fat of the whole body, trunk, arms and legs were derived from a whole body DEXA scan. Isokinetic knee extensor strength (KES) and flexor strength (KFS) at 30°?·?s–1 were assessed using an isokinetic dynamometer. The women aged 71–87 years had 35% lower KES and KFS than the women aged 18–40 years (P 0.0001). Differences in LM were less pronounced. The LM of the legs, for instance, was 15% lower in the old than in the young women (P 0.0001). In a multiple regression analysis with age, body mass, height and leg LM or KES as independent variables and KES or leg LM as the dependent variable, age was the most important predictor of KES (r partial?=??0.74, P 0.0001). The same applied to KFS. Body mass, not age, was the most important predictor of leg LM (r partial?=?0.65, P 0.0001) and of LM at all other measurement sites. The LM measured at different regions decreased equally with increasing age. The KES:leg LM ratio was negatively correlated with age (r?=??0.70, P 0.0001). The weight lifters had significantly higher KES:leg LM ratios than age-matched controls (+12%, P 0.0001) and vice versa for the women with previous hip fractures (–36%, P 0.0001). In conclusion, from our study it would seem that in healthy nonathletic women, age is a more important determinant of muscle strength than is LM as measured by DEXA. Muscle strengthening exercises and inactivity seem to have a considerably stronger influence on muscle strength than on LM. 相似文献
8.
Myosin VIIA gene: heterogeneity of the mutations responsible for Usher syndrome type IB 总被引:8,自引:1,他引:8
Levy G; Levi-Acobas F; Blanchard S; Gerber S; Larget-Piet D; Chenal V; Liu XZ; Newton V; Steel KP; Brown SD; Munnich A; Kaplan J; Petit C; Weil D 《Human molecular genetics》1997,6(1):111-116
Usher syndrome is recognized as the most frequent cause of hereditary
deaf-blindness. Usher syndrome type I (USH1), the most severe form of the
disease, is characterized by profound congenital sensorineural deafness,
constant vestibular dysfunction, and retinitis pigmentosa of prepubertal
onset. This form is genetically heterogeneous and five loci (USH1A-E) have
been mapped thusfar. However, only the gene responsible for USH1 B (which
accounts for approximately 75% of USH1 cases) has been characterized. It
encodes a long-tailed unconventional myosin, myosin VIIA, with a predicted
2215 amino acid sequence. Primers covering the complete myosin VIIA coding
sequence as well as the 3' non coding sequence were designed, allowing
direct sequence analysis of each of the 48 coding exons and flanking splice
sites in seven patients affected by USH1. Four novel mutations were thereby
identified. The possibility should now be considered of a sequence-based
prenatal diagnosis in some of the families affected by this very severe
form of Usher syndrome.
相似文献
9.
10.